Obesity: An urgent focus for health promotion at work

  • November 13, 2018
  • Comments off

bh in Brief Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat obesity, hemophilia, growth disorders and other serious chronic diseases. Headquartered in Denmark, Novo Nordisk employs approximately 41,700 […]

Read More

Migraines: A Misunderstood Workplace Issue By Elizabeth Leroux, MD, FRCPC

  • May 14, 2018
  • Comments off

The writing and publication of these articles were sponsored by Novartis Pharma Canada.   References  1. Steiner TJ, Stovner LJ, Vos T. GBD 2015: migraine is the third cause of disability in under 50s. J Headache Pain. 2016;17:104. 2. Steiner TJ, Stovner LJ, Vos T, Jensen R, Katsarava Z. Migraine is first cause of disability […]

Read More

Clinical Depression: Biomarkers Not a Smile

  • November 4, 2017
  • Comments off

  Changes in the brain can serve as biomarkers for prevention and early detection of depression. They can also predict responses to various treatments or the possibility of relapse. CAN-BIND researchers are working to identify these and other biomarkers of depression. References 1 Stonebridge, C. & G. Sutherland. 01 September 2016. Healthy Brains at Work: […]

Read More

Innovations in Medical Technology – Diabetes

  • May 6, 2017
  • Comments off

bh in Brief LifeScan Canada Ltd., a Johnson & Johnson company and the manufacturer of OneTouch® blood glucose monitoring products, is dedicated to creating a world without limits for people with diabetes. Through its industry-leading OneTouch® products and award winning customer support, LifeScan Canada provides comprehensive blood glucose monitoring systems tailored to meet the needs […]

Read More

Multiple Sclerosis: The Mystery of Invisible Disabilities

  • October 27, 2016
  • Comments off

  bh IN BRIEF From our approach to clinical trials for new drug therapies, to industry partnerships and community involvement, Roche Canada is a leader in providing pharmaceutical and diagnostic solutions that make a profound difference in people’s lives. Our innovative approach improves the effectiveness and efficiency of the healthcare system in the diagnosis, treatment […]

Read More

Cardiovascular Disease – Managing the Impact on Workplaces

  • April 19, 2016
  • Comments off

bh in Brief Globally, Amgen is a leading human therapeutics company. Since 1991, Amgen Canada has been an important contributor to Canada’s biotechnology sector, applying science and innovation to fight illness and dramatically improve people’s lives, and contributing to philanthropic efforts in the community.  Amgen Canada supports education initiatives that help Canadians through the cancer […]

Read More

The Team Approach to Type 2 Diabetes: What Research Can Tell Us

  • October 29, 2015
  • Comments off

bh in Brief AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialization of prescription medicines. Our primary focus is on three important areas of healthcare: Cardiovascular and Metabolic disease (CVMD); Oncology; and Respiratory, Inflammation and Autoimmunity (RIA). AstraZeneca operates in over 100 countries and its innovative medicines […]

Read More

Leadership When Chronic Illness Strikes

  • May 6, 2015
  • Comments off

bh in Brief CLL resources for patients and caregivers include: www.lymphoma.ca cllpag.ca www.llscanada.org Notes: 1 Government of Canada. 2014, November. When Work and Caregiving Collide: How Employers Can Support Their Employees Who Are Caregivers . Report of the Employer Panel for Caregivers. Ottawa, ON: Canadian Employers for Caregivers Plan (CECP). Available: www.esdc.gc.ca/eng/seniors/reports/cec.shtml   Inevitably, descriptions […]

Read More

Beyond Borders … Perspectives on Inflammatory Disease

  • November 7, 2014
  • Comments off

bh IN BRIEF “The stories and artworks in Perspectives may contribute to the current understanding of these diseases and their impact on patients and society from a very personal and emotional point of view. AbbVie is a global, research-based biopharmaceutical company committed to addressing some of today’s toughest health challenges. Helping others understand the impact […]

Read More

The Wide Reach of Psoriasis: The “Greater Patient”Concept

  • February 27, 2014
  • Comments off

Andrew Gosse bh IN BRIEF This article is based on a bh interview with Andrew Gosse of St John’s Newfoundland, founder and president of the Canadian Psoriasis Network (CPN), a national not-for-profit organization whose focus is on research, outreach, education and support for Canadians living with psoriatic disease. Its goal is to improve the quality […]

Read More